000 01378 a2200373 4500
005 20250514040526.0
264 0 _c20020731
008 200207s 0 0 eng d
022 _a1525-4135
024 7 _a10.1097/00126334-200207010-00015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTortajada, Cecilia
245 0 0 _aHighly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cJul 2002
300 _a364-6 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntiretroviral Therapy, Highly Active
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aLeishmaniasis, Visceral
_xepidemiology
700 1 _aPérez-Cuevas, Bernardo
700 1 _aMoreno, Asuncion
700 1 _aMartínez, Esteban
700 1 _aMallolas, Jose
700 1 _aGarcía, Felipe
700 1 _aValls, Eugenia
700 1 _aMiró, José M
700 1 _aDe Lazzari, Esther
700 1 _aGatell, José M
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 30
_gno. 3
_gp. 364-6
856 4 0 _uhttps://doi.org/10.1097/00126334-200207010-00015
_zAvailable from publisher's website
999 _c12019735
_d12019735